CN104341433B - A kind of preparation method of prasugrel intermediate - Google Patents
A kind of preparation method of prasugrel intermediate Download PDFInfo
- Publication number
- CN104341433B CN104341433B CN201310335239.XA CN201310335239A CN104341433B CN 104341433 B CN104341433 B CN 104341433B CN 201310335239 A CN201310335239 A CN 201310335239A CN 104341433 B CN104341433 B CN 104341433B
- Authority
- CN
- China
- Prior art keywords
- compound
- preparation
- prasugrel
- reacts
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CC(C)(C)OC(N(CC1)Cc2c1[s]c(O*)c2)=O Chemical compound CC(C)(C)OC(N(CC1)Cc2c1[s]c(O*)c2)=O 0.000 description 3
- ZJRZMABINYJKGO-KLTFRVJNSA-N CC(C(C1)[C@@H]2SCC3)[C@H]2C3CN1C(OC(C)(C)C)=O Chemical compound CC(C(C1)[C@@H]2SCC3)[C@H]2C3CN1C(OC(C)(C)C)=O ZJRZMABINYJKGO-KLTFRVJNSA-N 0.000 description 1
- QJXCDRBHYIAFTH-MRVPVSSYSA-N C[C@H](CCCC1)C1=C Chemical compound C[C@H](CCCC1)C1=C QJXCDRBHYIAFTH-MRVPVSSYSA-N 0.000 description 1
- UZMACOFKHHDOTR-ZJUUUORDSA-N C[C@H](CN(CC1)C(OC(C)(C)C)=O)[C@H]1SCO Chemical compound C[C@H](CN(CC1)C(OC(C)(C)C)=O)[C@H]1SCO UZMACOFKHHDOTR-ZJUUUORDSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Abstract
The invention provides a kind of preparation method of prasugrel intermediate compound, this method includes the following steps:(1)Amido protecting reacts:4; 5,6,7 thiophanes simultaneously [3; 2 c] pyridine hydrochloride is raw material; target compound is obtained by halogenation, alkylated reaction, with sodium alkoxide deprotection reaction and HCl gas acidification reactions, this method is simple, and technique is advanced; the caused three wastes are few in production process; environmental protection pressure is small, and high income, suitable for industrialized production.
Description
Technical field
A kind of medical synthesis field of the present invention, and in particular to preparation side of anti-platelet aggregation medicine prasugrel intermediate
Method.
Background technology
Prasugrel(Prasugrel), chemical name:2- acetoxyl groups -5-(α-cyclopropyl carbonyl -2- luorobenzyls)- 4,5,
6,7- thiophanes simultaneously [3,2-c] pyridine, structural formula such as following formula(Ⅰ):
Prasugrel is as a kind of new oral anti-platelet aggregation medicine, by Japanese Sankyo companies and U.S. Eli
The joint development development of Lilly companies, and in 2 Yue23Huo European Union approval listing in 2009.Research shows the prevention of prasugrel
The effect of thrombus is stronger than the effect of clopidogrel, in experiments it is found that prasugrel can faster work, the trouble of prasugrel group
Thrombus after person's medication in blood is fewer than clopidogrel group, and prasugrel is suppressing than the clopidogrel of approval dosage at present
Effect in the cohesion of ADP induced platelets is more powerful, and the incidence of prasugrel group ischemic event reduces than clopidogrel group, general
The effect that glug thunder antiplatelet is built up is obvious and rapid.And in the code name of prasugrel clinical research it is JUMBO-TIMI26
In second stage research, prasugrel faster and more unified inhibits blood platelet than chlorine Gray really.
Patent US4740510 and EP0542411 disclose a kind of preparation method of prasugrel, and its synthetic route is as follows:
Patent CN101402506 also discloses that a kind of preparation method of prasugrel, and its synthetic route is as follows:
In both the above method, 2- oxygen -2,4,5,6,7,7a- hexahydro thieno [3,2-c] pyridine hydrochloric acid are all employ
Salt(Compound 1)Nucleophilic substitution occurs with adjacent luorobenzyl cyclopropyl ketone, is then acylated and obtains 2- acetoxyl groups -5-(a-
Cyclopropyl carbonyl -2- luorobenzyls)- 4,5,6,7- thiophanes simultaneously [3,2-c] pyridine(Prasugrel)But the mesh of starting compound 1
Before can not conveniently obtain, can be bought without cheap industrial goods.
Patent US4740510 discloses its a kind of preparation method, and its synthetic route is as follows:
This method be by 4,5,6,7- thiophanes simultaneously [3,2-c] pyridine be initiation material at low temperature with n-BuLi,
Butyl borate reacts to obtain 5- trityl -2- oxygen -2,4,5,6,7a- hexahydro thieno [3,2-c] pyridines, finally and formic acid
Reaction obtains.Its reaction condition is harsher, it is necessary to -40 DEG C of low temperature, while normal-butyl reason is inflammable and explosive, can give extensive raw
Production brings danger.
The system of 2- oxygen -2,4,5,6,7,7a- hexahydros thieno [3,2-c] pyridine hydrochloride is also disclosed that in EP192535
Preparation Method, but the step of patented method synthesis is more, yield is low, and synthesis cost is high, is unfavorable for the big production of lower industryization.
A kind of new intermediate for preparing prasugrel is disclosed in CN101245073A, but it selects benzyl protection, after
Continuous deprotection steps will be very difficult.Structural formula is as follows:
For the defects of yield is low, cost is high, environmental protection pressure is big present in synthesis prasugrel at present, further research
In high yield, inexpensive, green prasugrel synthetic method has wide market prospects, and this just needs to research and develop newly general
Glug thunder intermediate, guarantee is provided to improve the synthetic method of prasugrel.
The content of the invention
It is an object of the invention to overcome the deficiencies of the prior art and provide a kind of prasugrel important intermediate formula (1)
Preparation method.The structural formula of the prasugrel intermediate is as follows:
The preparation method of the present invention includes following steps:
1)Amido protecting reacts:Compound 1 and di-tert-butyl dicarbonate(BOC reagents)Reacted in dioxy naphthenic solvent
Compound 2
2)Halogenation:Compound 2 occurs halogenation under halogenating agent effect and obtains compound 3
3)Alkylated reaction:Rudimentary sodium alkoxide below the carbon of compound 3 and six reacts to obtain compound 4, wherein R represent six carbon with
Lower alkyl
4)Deprotection reaction:Compound 4 obtains compound 1 with HCl gas reactions
Above-mentioned steps 1), solvent used includes during reaction:Alcohol, esters, dioxy cycloalkanes, dichloromethane, tetrahydrofuran,
Benzene, toluene, acetonitrile, DMF etc., preferably dioxy cycloalkanes, 60-100 DEG C of reaction temperature, preferable temperature are 80 DEG C.
Above-mentioned steps 2), halogenating agent used is CuCl during halogenation2Or CuBr2, preferably CuCl2, solvent for use is methanol.
Above-mentioned steps 3), sodium alkoxide used is the following sodium alkoxide of six carbon, and preferably sodium methoxide, solvent for use are methanol.
Above-mentioned steps 4), solvent for use is methanol, and HCl is the saturation methanol solution of the gas, and reaction terminates rear crude product and used
Acetone, isopropyl ether are refined to obtain compound 1.
The beneficial effects of the present invention are:
Raw material used in the preparation method of the present invention is easy to get, while this method reaction condition is gentle, it is not necessary to ultralow
Reacted under the conditions of temperature, it is safe suitable for large-scale industrial production without using inflammable and explosive reagent, and reaction yield is more
Height, cost are lower.
Prasugrel intermediate disclosed by the invention(Compound 1), its preparation method is simple, and technique is advanced, production process
In the caused three wastes it is few, environmental protection pressure is small, and high income, suitable for industrialized production.
Embodiment
Now beneficial effects of the present invention are further described by following examples, it is thus understood that these embodiments are only used for
The purpose of illustration, is not limited the scope of the invention, at the same those of ordinary skill in the art according to the present invention done it is apparent
Change and modification be also contained within the scope of the invention.
5- tertbutyloxycarbonyl -4,5,6,7- the thiophanes of embodiment 1 simultaneously [3,2-c] pyridine(Compound 2)Preparation:
By 4,5,6,7- thiophanes simultaneously [3,2-c] pyridine hydrochloride(Compound 5)12.6g adds 250ml three-necked flasks
In, 150ml dioxane is added into three-necked flask, mechanical agitation is simultaneously dissolved quickly with warming-in-water, raw material, when temperature rises to 80
DEG C when, add 15.2gk2CO30.5h is stirred, di-tert-butyl dicarbonate 16.5g is added dropwise, continues stirring reaction 1h, stops reacting and be down to
Room temperature, filtering, filtrate add 200ml ethyl acetate and 200ml ammoniacal liquor to stir, and liquid separation, ethyl acetate layer washing, salt are washed, dried, dense
It is reduced to dry that 16.8g had both been compound 2.
The chloro- 5- tertbutyloxycarbonyls -4,5,6,7- thiophanes of the 2- of embodiment 2 simultaneously [3,2-c] pyridine(Compound 3)System
It is standby:
Add 15.8g compounds 2 into 250ml three-necked flasks, add 200ml methanol stirring and dissolvings, add 5.6gCuCl2Continue to stir
Reaction 4h is mixed, stops reacting, adds 200ml ethyl acetate and 300ml saturated sodium bicarbonate solutions to stir, liquid separation, ethyl acetate layer water
Wash, salt is washed, dry, be concentrated to dryness 18.8g had both been compound 3
2- methoxyl group -5- tertbutyloxycarbonyl -4,5,6,7- the thiophanes of embodiment 3 simultaneously [3,2-c] pyridine(Compound 4)
Preparation:
By 18g compounds 3,11.5g sodium methoxides are added in 250ml three-necked flasks, add 150ml methanol, magnetic agitation, in nitrogen
24h is heated to reflux under gas shielded, is cooled down, filtering, filtrate adds 200ml ethyl acetate and 300ml pure water to stir, liquid separation, acetic acid second
Ester layer washing, salt are washed, dried, and are concentrated to dryness to obtain crude product, are crossed silicagel column purifying, are obtained 8.4g compounds 4.
Embodiment 4 2- oxygen -2,4,5,6,7,7a- hexahydros thieno [3,2-c] pyridine hydrochloride(Compound 1)System
It is standby:
16g compounds 4 are dissolved in the homemade methanol hydrochloride solutions of 300ml, leads to HCl gases, 12h is stirred at room temperature, will
Reaction solution is concentrated to dryness, and with 200ml acetone solutions, 400ml isopropyl ethers are added dropwise, has a large amount of crystal to separate out, filters, dries to obtain 6.5g
Compound 1.
Claims (5)
- A kind of 1. preparation of hexahydro thieno [3,2-c] pyridine hydrochlorides of prasugrel intermediate 2- oxygen -2,4,5,6,7,7a one Method, it is characterised in that including following steps:1) amido protecting reacts:Compound 5 reacts to obtain chemical combination with di-tert-butyl dicarbonate in 1,4- dioxanes Thing 22) halogenation:Compound 2 occurs halogenation under halogenating agent effect and obtains compound 33) nucleophilic substitution:Compound 3 reacts to obtain compound 4 with sodium methoxide, and wherein R represents methyl4) deprotection reaction:Compound 4 leads to HCl gas reactions after dissolving and obtains compound 1Halogenating agent used in step 2) is copper chloride;Solvent used in step 3) is absolute methanol;Solvent used in step 4) is methanol hydrochloride solution.
- 2. preparation method as claimed in claim 1, it is characterised in that the reaction temperature of step 1) is 60-100 DEG C.
- 3. preparation method as claimed in claim 1, it is characterised in that the reaction temperature of step 1) is 80 DEG C.
- 4. preparation method as claimed in claim 1, it is characterised in that the solvent used in step 2) is methanol.
- 5. preparation method as claimed in claim 1, it is characterised in that step 4) is passed through HCl gases and keeps solution saturation.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310335239.XA CN104341433B (en) | 2013-08-02 | 2013-08-02 | A kind of preparation method of prasugrel intermediate |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310335239.XA CN104341433B (en) | 2013-08-02 | 2013-08-02 | A kind of preparation method of prasugrel intermediate |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104341433A CN104341433A (en) | 2015-02-11 |
CN104341433B true CN104341433B (en) | 2017-12-15 |
Family
ID=52497957
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310335239.XA Active CN104341433B (en) | 2013-08-02 | 2013-08-02 | A kind of preparation method of prasugrel intermediate |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104341433B (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740510A (en) * | 1985-01-31 | 1988-04-26 | Sanofi (S.A.) | Derivatives of alpha-(2-oxo 2,4,5,6,7,7a-hexahydro thieno[3,2-c]5-pyridyl) phenyl acetic acid, and their use as platelet and thrombotic aggregation inhibitors |
WO1999027929A1 (en) * | 1997-12-04 | 1999-06-10 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
CN101245073A (en) * | 2008-03-21 | 2008-08-20 | 上海医药工业研究院 | Medicine midbody and preparation method thereof |
CN101985451A (en) * | 2010-11-02 | 2011-03-16 | 北京赛科药业有限责任公司 | Preparation method of prasugrel intermediate |
CN102002056A (en) * | 2010-11-02 | 2011-04-06 | 北京赛科药业有限责任公司 | Method for preparing intermediate of prasugrel |
-
2013
- 2013-08-02 CN CN201310335239.XA patent/CN104341433B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740510A (en) * | 1985-01-31 | 1988-04-26 | Sanofi (S.A.) | Derivatives of alpha-(2-oxo 2,4,5,6,7,7a-hexahydro thieno[3,2-c]5-pyridyl) phenyl acetic acid, and their use as platelet and thrombotic aggregation inhibitors |
WO1999027929A1 (en) * | 1997-12-04 | 1999-06-10 | Merck & Co., Inc. | Inhibitors of farnesyl-protein transferase |
CN101245073A (en) * | 2008-03-21 | 2008-08-20 | 上海医药工业研究院 | Medicine midbody and preparation method thereof |
CN101985451A (en) * | 2010-11-02 | 2011-03-16 | 北京赛科药业有限责任公司 | Preparation method of prasugrel intermediate |
CN102002056A (en) * | 2010-11-02 | 2011-04-06 | 北京赛科药业有限责任公司 | Method for preparing intermediate of prasugrel |
Non-Patent Citations (1)
Title |
---|
盐酸普拉格雷合成路线图解;李素义 等;《中国医药工业杂志》;20101130;第41卷(第11期);第869-872页 * |
Also Published As
Publication number | Publication date |
---|---|
CN104341433A (en) | 2015-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104250232A (en) | Preparation method of parecoxib sodium | |
CN105294653B (en) | The preparation technology of Vonoprazan fumarate | |
CN103724261A (en) | Novel industrial production method for hydroxychloroquine sulfate | |
CN106632244A (en) | A novel synthetic method for preparing an anticancer medicine Niraparib | |
CN106496187A (en) | A kind of synthetic method for preparing PARP inhibitor Niraparib | |
CN107778223B (en) | Preparation method of betrixaban maleate | |
CN106008290A (en) | Method for preparing tembotrions | |
CN109575014A (en) | Benzimidazole simultaneously [2,1-a] isoquinolinone compound and preparation method thereof | |
CN109988077A (en) | A kind of synthetic method and intermediate of A Palu amine | |
CN103159677B (en) | The preparation method of IQL | |
CN106749259A (en) | A kind of synthetic method of cyclopenta pyrimido azoles | |
CN105061405A (en) | Preparation method of fimasartan potassium salt hydrate | |
CN104370935B (en) | A kind of preparation method of bisulfate clopidogrel | |
CN109867673A (en) | A method of synthesis Pabuk former times benefit cloth | |
CN104163786B (en) | A kind of method preparing 5-methyl-3-bromo methyl cycloheptapyridine hydrobromate | |
CN106866707A (en) | A kind of preparation method of benzimidazole simultaneously [2,1 b] thiazole | |
CN104341433B (en) | A kind of preparation method of prasugrel intermediate | |
CN104311493A (en) | Azoxystrobin synthesis method | |
CN104768936A (en) | Enzalutamide polymorphic forms and its preparation | |
CN106588921B (en) | A kind of synthetic method of the methyl formate of 7 azaindole 3 | |
CN104829588B (en) | A kind of Preparation Method And Their Intermediate of benzo [b] thiophene | |
CN107118088A (en) | A kind of preparation method of m-hydroxy acetophenone | |
CN106749138B (en) | A kind of preparation method of sulfuric acid Walla pa sand intermediate aldehydes | |
CN104163793A (en) | Preparation method of roflumilast | |
CN106588786A (en) | Preparation method of high purity favipiravir impurity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |